Jack Fernandes

Mr. Fernandes left a hedge fund in Irvine to expand upon theories he generated while following biotechnology companies. He pursued a career as an FDA regulatory strategist, ultimately working in both Corporate and Intellectual Property at several pharmaceutical companies including Kite Pharma, Gilead Sciences, and San Diego-based Innovus Pharma. He was also formerly the principal consultant to UCLA’s Business of Science Center where he helped turn academic research into drug companies. Mr. Fernandes holds a B.A. from Claremont Mckenna College and a J.D. from UCLA School of Law with a specialization in Mergers & Acquisitions, where he served as the Senior Staff Editor on UCLA’s law review.